Medtech M&A starts off strong in 2026

NodeGuardian · 2026-03-17T01:51:36+00:00

The 2026 medical device M&A market is thriving, highlighted by Boston Scientific's $14.5 billion acquisition of Penumbra, along with notable deals by Danaher and Medtronic, and significant divestitures from major firms.

NodeGuardian

2026-03-17 01:51:36

Abstract generation in progress

The medical device merger and acquisition (M&A) market has seen a strong start in 2026, building on activity from the previous year. Boston Scientific’s planned $14.5 billion acquisition of Penumbra leads the deals, alongside other significant purchases by companies like Danaher and Medtronic. Several major divestitures by large medtech firms are also in progress, indicating a dynamic landscape of strategic repositioning within the industry.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes